James Expert Has Update on Breakthrough Leukemia Drug

A promising new drug developed right here at The James is showing remarkable success with certain leukemia patients.

According to leukemia expert Dr. John Byrd, the drug known as acalabrutinib is a targeted medicine that goes after a protein found in chronic lymphocytic leukemia (CLL) and can actually turn that protein off—leading to remarkable patient response and often a return to regular daily activities.

Blog Logo

Upcoming Events

Shopping with the Experts: Fresh Thyme - Tour #1 (6-7pm)

3/21/2018 6:00:00 PM - 3/21/2018 7:00:00 PM

933 N. High Street
Worthington, Ohio 43085


Melanoma Support Group

3/21/2018 6:30:00 PM - 3/21/2018 7:30:00 PM

1145 Olentangy River Road
Columbus, Ohio 43212


View More